• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Annexon, Inc. - common stock (NQ:ANNX)

    4.160 +0.960 (+30.00%)
    Streaming Delayed Price Updated: 1:22 PM EST, Nov 19, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Annexon, Inc. - common stock

    < Previous 1 2 3 4 5 6 7 Next >
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Analyst Ratings for Annexon ↗
     
    Via Benzinga
    News headline image
    Annexon Presents ARCHER Trial Results at ASRS 2023 Highlighting Potential of ANX007 as a Differentiated Treatment for Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Analyst Expectations for Annexon's Future ↗
     
    Via Benzinga
    News headline image
    Why Annexon (ANNX) Stock Is Getting Hammered ↗
    Annexon Inc (NASDAQ: ANNX) shares are trading lower by some 57.16% to $2.96 Thursday morning. 
    Via Benzinga
    News headline image
    Annexon's Eye Disease Drug Reports Mixed Trial Results, Will Focus On Planned Late-Stage Study ↗
     
    Via Benzinga
    News headline image
    Analyst Ratings for Annexon ↗
     
    Via Benzinga
    News headline image
    Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRS 2023
    Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ET 
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    The Latest Analyst Ratings for Annexon ↗
     
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2023 ↗
     
    Via Benzinga
    News headline image
    Crude Oil Drops Sharply; Best Buy Earnings Top Expectations ↗
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining more than 200 oints on Thursday. The Dow traded down 0.02% to 32,793.29 while the NASDAQ rose 1.78% to 12,706.89.... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Nasdaq Surges 1.5%; NVIDIA Shares Jump Following Strong Q1 Results ↗
    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 1.5% on Thursday. The Dow traded down 0.20% to 32,733.60 while the NASDAQ rose 1.53% to 12,674.85. The S&P 500,... 
    Via Benzinga
    News headline image
    Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
    Gainers Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 211.6% to $6.86 after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR. 
    Via Benzinga
    News headline image
    Why Shares of Annexon Are Plummeting Thursday ↗
    Mixed trial results on a geographic atrophy eye drug led investors to sell the biotech stock. 
    Via The Motley Fool
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023 ↗
     
    Via Benzinga
    News headline image
    Dow Drops 100 Points; US GDP Tops Estimates ↗
    U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining over 1% on Thursday. Following the market opening Thursday, the Dow traded down 0.34% to 32,687.15 while the NASDAQ rose 1.36%... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
    We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
    Via InvestorPlace
    News headline image
    Annexon Topline Data from ARCHER Phase 2 Trial of ANX007 in Geographic Atrophy Demonstrated Statistically Significant, Dose-Dependent Preservation of Visual Function
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports First Quarter 2023 Financial Results and Highlights Recent Pipeline Progress
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Participate in the 22nd Annual Needham Virtual Healthcare Conference
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Participate in the 43rd Annual Cowen Healthcare Conference
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.